z-logo
open-access-imgOpen Access
Antiamnesic Effects of a Hydroethanolic Extract of Crinum macowanii on Scopolamine-Induced Memory Impairment in Mice
Author(s) -
Andrew T. Mugwagwa,
Louis L. Gadaga,
William Pote,
Dexter Tagwireyi
Publication year - 2015
Publication title -
journal of neurodegenerative diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.4
H-Index - 3
eISSN - 2090-858X
pISSN - 2090-8601
DOI - 10.1155/2015/242505
Subject(s) - amnesia , memory impairment , scopolamine , acetylcholinesterase , pharmacology , donepezil , aché , medicine , cholinergic , psychology , traditional medicine , neuroscience , cognition , chemistry , dementia , disease , biochemistry , enzyme , psychiatry
Crinum macowanii has been found to contain alkaloids that have activity against acetylcholinesterase enzyme in vitro . The present study was undertaken to investigate the in vivo ability of hydroethanolic crude extract of Crinum macowanii to ameliorate memory impairment induced by scopolamine. Thirty-six male Balb/c mice weighing around 25–35 g were employed in the present investigation. Y-maze and novel object recognition apparatus served as the exteroceptive behavioural models, and scopolamine-induced amnesia served as the interoceptive behavioural model. C. macowanii (10, 20, and 40 mg/kg p.o.) was administered in single doses to the mice. Donepezil (3 mg/kg p.o.) was used as a positive control agent. C. macowanii extract reversed the amnesia induced by scopolamine as indicated by a dose-dependent increase in spontaneous alternation performance in the Y-maze task. C. macowanii 40 mg/kg showed significant activity ( p < 0.05 versus negative control), comparable to that of the positive control. C. macowanii also showed memory-enhancing activity against scopolamine-induced memory deficits in the long-term memory novel object recognition performance as indicated by a dose-dependent increase in the discrimination index. The results indicate that the hydroethanolic extract of C. macowanii may be a useful memory restorative mediator in the treatment of cognitive disorders such as Alzheimer's disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom